Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 5/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | METAP2 | P50579 | 1/20 | 0.39 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.39 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.39 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.39 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 4/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.39 |
| ▸ | RELA | Q04206 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30273511 | 1.00 | CYP2D6 (0.51) | CYP2D6RAB9ASMN1; SMN2KDM4EMEN1 | |
| SCHEMBL28078259 | 0.98 | CYP2D6 (0.50) | CYP2D6RAB9ASMN1; SMN2KDM4EMEN1 | |
| SCHEMBL9903935 | 0.89 | CYP2D6 (0.60) | CYP2D6LMNAMAPTHDAC4MAPK10 | |
| SCHEMBL8695286 | 0.82 | CYP2D6 (0.60) | CYP2D6RAB9ASMN1; SMN2KDM4EMEN1 | |
| SCHEMBL8499115 | 0.81 | CYP2D6 (0.53) | CYP2D6RAB9ALMNAMAPTMAPK10 | |
| SCHEMBL28135256 | 0.81 | MAPK14 (0.40) | CYP2D6RAB9ASMN1; SMN2KDM4EMEN1 | |
| SCHEMBL15651713 | 0.78 | CYP2D6 (0.51) | CYP2D6RAB9ASMN1; SMN2KDM4EMEN1 | |
| SCHEMBL675705 | 0.78 | CYP2D6 (0.51) | CYP2D6MAPTHDAC4MAPK10MAPK14 | |
| SCHEMBL2562967 | 0.78 | CYP2D6 (0.56) | CYP2D6RAB9ASMN1; SMN2KDM4EMEN1 | |
| SCHEMBL1061567 | 0.78 | CYP2D6 (0.51) | CYP2D6MAPTHDAC4METAP2MAPK10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4737448-A1 | SARM1 ENZYME ACTIVITY INHIBITOR AND USE THEREOF | Artivila (ShenZhen) Innovation Center, Ltd. (CN) | 2026-05-06 | — | — | EP | disclosed |
| WO-2025002030-A1 | SARM1 ENZYME ACTIVITY INHIBITOR AND USE THEREOF | 科辉智药(深圳)新药研究中心有限公司 | 2025-01-02 | — | — | WO | disclosed |
| CN-100577649-C | Electroluminescent device | CIBA SC HOLDING AG | 2010-01-06 | — | — | CN | disclosed |
| CN-1708485-A | Electroluminescent device | CIBA SC HOLDING AG (CH) | 2005-12-14 | — | — | CN | disclosed |
| US-5780473-A | Substituted biphenyl sulfonamide endothelin antagonists | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-07-14 | — | — | US | disclosed |
| US-5760038-A | Substituted biphenyl sulfonamide endothelin antagonists | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-06-02 | — | — | US | disclosed |
| EP-0725067-A1 | Substituted biphenyl sulfonamide endothelin antagonists | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-08-07 | — | — | EP | disclosed |
| EP-0508999-A1 | PHARMACEUTICALLY ACTIVE NORMONYL COMPOUNDS | Beecham Group p.l.c. (GB) | 1992-10-21 | — | — | EP | disclosed |
| WO-1991009855-A1 | PHARMACEUTICALLY ACTIVE NORMONYL COMPOUNDS | BEECHAM GROUP PLC (GB) | 1991-07-11 | — | — | WO | disclosed |